Page last updated: 2024-08-17

1,2,3,4-tetrahydroisoquinoline and Autosomal Dominant Juvenile Parkinson Disease

1,2,3,4-tetrahydroisoquinoline has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antkiewicz-Michaluk, L; Romańska, I; Wąsik, A1
Abe, K; Chida, S; Horiguchi, Y; Hoshi, K; Katagiri, N; Kitabatake, M; Nojima, H; Taguchi, K1
Fujitani, M; Kotake, Y; Makino, Y; Ohta, S; Shintani, H; Yamakawa, T1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T1
Abe, K; Ishiwata, K; Kawamura, K; Koyanagi, Y; Saitoh, T; Sano, T; Senda, M; Taguchi, K; Toda, J1

Other Studies

5 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Neurotoxicity research, 2016, Volume: 30, Issue:4

    Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agents; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Rats, Wistar; Tetrahydroisoquinolines; Time Factors

2016
Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice.
    Brain research, 2010, Mar-19, Volume: 1321

    Topics: Animals; Brain; Hypokinesia; Immunohistochemistry; Mice; Neuroprotective Agents; Parkinsonian Disorders; Stereoisomerism; Tetrahydroisoquinolines

2010
Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Neuroscience letters, 1999, Nov-26, Volume: 276, Issue:1

    Topics: Animals; Brain; Isoquinolines; Macaca fascicularis; Parkinsonian Disorders; Tetrahydroisoquinolines; Tissue Distribution

1999
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Brain research bulletin, 2001, Sep-01, Volume: 56, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

2001
Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
    Journal of neurochemistry, 2001, Volume: 79, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hypokinesia; Isoquinolines; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine D2; Stereoisomerism; Substantia Nigra; Synapses; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase; Up-Regulation

2001